Nagy, Bálint
Cell-Free Nucleic Acids
English[eng]
n/a||screening||single nucleotide polymorphism||predictive and preventive approach||PTEN||cell-free DNAs||fetal fraction||gestational hypertension||RASSF1||CDH1||RT-PCR||cfDNA||statistical models||hematopoietic stem cell transplantation||NanoString||solid organ transplantation||copy number variants||sarcomas||liquid biopsy||obesity||fetal DNA||neutrophil extracellular traps||mammography||non-invasive prenatal testing||ovarian cancer||circulating miRNA||pyrosequencing||growth retardation||preeclampsia||gestational diabetes mellitus||biomarker||inflammatory bowel disease||multi-level diagnostics||PAX1||population study||nuclease activity||NETosis||omics||piRNA||cell-free DNA||prediction||leiomyosarcomas||network analysis||NGS||statistical methods||circulating nucleic acids||deletion/insertion polymorphism||gender differences||leiomyomas||fetal growth restriction||blood plasma||exosomes||miRNA||pregnancy-related complications||NIPT||genetic marker||cell-free nucleic acids||extracellular vesicles||expression||next generation sequencing||breast cancer||individualized patient profile||circulating tumor cells||maternal serum screening||personalized medicine||embryo culture medium||C19MC microRNA||DNA||cell-free RNAs||z-score||fetal cells||microchimerism||aging||plasma